Global Exocrine Pancreatic Insufficiency Clinical Trials Sponsor Type and Drugs Review, H2, 2017

Market Research HUB

Albany, New York, September 22, 2017: To Understand the Pharmaceutical Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2017, provides an overview of Exocrine Pancreatic Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Exocrine Pancreatic Insufficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

Request For Free Sample Report:

Market Research Hub Clinical Trial Reports are generated using Market Research Hub’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.


– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Browse Full Report with TOC:

Table of Content:

Market Research Hub Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Exocrine Pancreatic Insufficiency 33
Jul 10, 2017: Anthera Pharmaceuticals Announces Phase 3 Clinical Study of Sollpura will be included in the Cystic Fibrosis Foundation Therapeutics Development Network 33
Jul 06, 2017: Anthera Announces Expansion of Screening in European Sites in Phase 3 RESULT Clinical Study of Sollpura 33
Clinical Trial Profile Snapshots 34
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About MRH 79
Contact Us 79
Source 79


Enquire About This Report:

About Market Hub

Market Hub (MRH) is a next-generation reseller of reports and analysis. MRH’s expansive collection of Pharmaceutical industry market has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States

Toll Free: 800-998-4852 (US-Canada)
Read Industry News at –

%d bloggers like this: